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We introduce  a  new effective  method  to  control  hormone refractory 
prostate cancer cells by using an activated rubber/resin form (RB), far-
infrared ray emitter, with or without sodium butyrate (SB). The growth of 
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three human prostate cancer cell lines (Du145, PC-3 and LNCaP) was 
suppressed in vitro and vivo by using RB, and the cells were eradicated 
with  RB + 3  mM SB.  G1 arrest  and apoptotic  pathway proteins were 
induced by RB with intensified expressions of apoptosis - related mRNA 
on cDNA microarray. RB radiates far-infrared rays of  the 4 to 25 mμ  
wavelengths to an object which exert a favorable influence on a cancer 
control.  These  results  may  render  us  a  new therapeutic  modality  in 
hormone refractory prostate cancer.
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Prostate cancer is the most common malignancy in men in the USA, with 218,890 
new cases and 27,050 deaths estimated in 2007.  Treatment options for early-stage 
prostate cancer are well defined, and localized prostate cancer can be cured by several 
therapeutic  strategies.  However,  the  outcome  is  still  disappointing  in  advanced 
prostate cancer. A variety of chemotherapeutic approaches, including docetaxel, have 
been  tried  to  control  hormone-refractory  prostate  cancer,  but  none  are  yet  fully 
satisfactory  in  terms of  complete cure,  with the least  number  of  side effects.  An 
effective new modality for the treatment of hormone refractory prostate cancer is 
urgently needed. 
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  Current  studies  on  cancer  control  have  focused  on  cancer-specific  genes  and 
proteins to control cancer, with which there are some expectations of cancer control 
in vitro and/or in vivo. However, the most difficult issue in studies of cancer control is 
the cancer itself, since it is already established when it is studied. We know that it 
constantly changes its own DNA arrangement and increases in size, which leads to 
the death of the host. Cancer cells also have normal active genes for their survival and 
growth.  On  the  other  hand,  genes  to  suppress  cancer  growth  might  become 
considerably  silent  during  cancer  growth.  It  is  also  considered  that  apoptotic 
pathways in cancer cells are inactivated or weakened. It will be then very effective in 
cancer control if such an oncogenic environment in a man with cancer whose death 
pathways of cancer cells become silent is  improved by applying a new method to 
reactivate  silent  and/or  weakened pathways of  apoptosis  and its  related genes.  In 
order to reactivate these silent genes, we focused on both far-infrared rays and sodium 
butyrate (SB), natural histone deacetylase inhibitors (HDACi) in human intestine. 
  Under conditions in which the DNA loop is open widely for SB, and more active 
movements of molecules in nuclei occur with an increase of the temperature induced 
by far-infrared rays, various transcription factors have more efficient access to the 
promoter region of the structural genes. 
  For  this  purpose,  we chose  an  activated  rubber/resin  form made  of  natural  or 
synthetic  rubber/resin  (RB) originally  applied  to  a  wetsuit,  and  known to be  far-
infrared ray emitter. We assessed the ability of this activated form in combination 
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with SB to control human prostate cancer cells such as DU145, PC-3 and LNCaP. 
Furthermore, we propose a new concept to explain the observed efficacy of RB in the 
growth control of prostate cancer cells using the Planck and Arrhenius formula. RB 
increased the temperature by 0.36°C constantly in the area exposed, which resulted in 
the reactivation of mRNA expression of apoptotic pathways in the prostate cancer 
cells  on  cDNA  microarray  analysis.  These  phenomenon  by  RB  were  confirmed 
through a set of both  in vitro and  in vivo experiments. This could be theoretically 
brought  by  the  effects  of  the  structure-based  substance  wave  at  a  frequency  of 
2.27×1033/s radiated from the molecules by resonance when exposed to far-infrared 
rays. 
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Spectral emissivity in the infrared region
Spectral emittance from 4 to 25 m was close to 100 % (Fig.1a). Transmissivity wasμ  
Zero  (0)  at  4000  -  400cm-1 (Data  not  shown).  The  temperature  of  the  medium 
increased by 0.36°C (37.32 ± 0.405  vs 37.68 ± 0.440,  n = 12) by far-infrared rays 
emitted from RB which were placed up and down outside the culture dish (Fig.1b).   
Effects of RB ±SB on prostate cancer cells
We started the following experiments after the cell culture for 21 days with or without 
RB.  Since  preliminary  cDNA  microarray  of  the  cancer  cells  cultured  showed 
incremental  increases of  mRNA expression from the 1st day to 21 days (Data not 
shown). We observed a significant decrease in cell proliferation in DU145, PC-3, and 
LNCaP cell lines after 29 days of treatment (Fig.1c). However, each cell line showed a 
somewhat different response to RB, SB and RB+SB. After 29 days, RB inhibited cell 
proliferation by 59.2% (P<0.0001) in DU145 cells (Fig. 2a and Supplementary Table 
1),  56.9%  P<0.0001)  in  PC-3  (Fig.  2b  and  Supplementary  Table  1),  and  31.5% 
(P<0.0001) in LNCaP cells  (Fig.  2c and Supplementary  Table 1).  Treatment  with 
RB+SB (2 mM) showed a stronger inhibition of cell growth than treatment with 2mM 
SB  alone  after  29  days:  4.4-99.1%  (P<0.0001)  in  DU145  cells  (Fig.  2a  and 
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Supplementary  Table  1),  27.7-93.4%  (P<0.0001)  in  PC-3  cells  (Fig.  2b  and 
Supplementary  Table  1)  and 87.7-100% (P<0.0001)  in  LNCaP cells  (Fig.  2c  and 
Supplementary Table 1). The cells (DU145, PC-3 and LNCaP) with RB attachment 
died  in  the  presence  of  3mM SB.  These  date  indicated  that  hormone-refractory 
prostate  cancer  cells  DU145 and  PC-3  were  significantly  suppressed  by RB+SB, 
which had a stronger growth inhibitory effect than that of SB alone.
  Human prostate epithelial cells were subjected to the same treatment. After 21 (RB) 
+ 8 (SB + RB) days, 1, 2 and 3 mM SB inhibited cell proliferation by 27.3% (P<0.01), 
24.0% (P<0.01) and 24.3% (P<0.01), respectively (Fig. 2d and Supplementary Table 
1).  Surprisingly,  we  observed  a  significantly  increase  in  the  number  of  normal 
prostate epithelial cells following RB+SB treatment. Twenty one (RB) + 8 (SB + RB) 
days treatment with RB+SB (0, 1, 2 and 3 mM) increased the number of cells by 
69.5%  (P<0.01),  53.6%  (P<0.001),  50.0%  (P<0.001)  and  192.8%  (P<0.0001), 
respectively (Fig. 2d and Supplementary Table 1). These results suggest that RB is 
not  toxic  to  human  prostate  epithelial  cells,  but  SB is  toxic  to  a  certain  extent. 
Interestingly, RB increased the number of human prostate epithelial cells in culture. 
Gene expression on cDNA microarray
Expression  of  mRNA  in  the  presence  of  RB  was  recognized  from  day  1,  and 
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increased  up  to  day  21 in  the  preliminary  experiment.  Representative  results  of 
hierarchical clustering human cDNA (1.2k) microarray analysis after 21 and 28 days’ 
exposure of cells to RB is shown in Fig. 3a. RB showed remarkable activation of 
mRNA in DU145, PC-3 and LNCaP cells after 21 and 28 days. In combination of 2 
mM SB for 7 days whose culture medium were exposed by RB for 21 days, mRNA 
expression was significantly up-or down regulated in this group in comparison with 
that without RB. Messenger RNA for TNF associated genes related to apoptosis was 
strongly  expressed  which  was  confirmed  by RT-PCR (Fig.  3b).  Messenger  RNA 
related to MAP kinase and ubiquities pathways were not activated by RB (data not 
shown).
Effect of RB on the prostate cancer cell cycle 
In the cell cycle analysis, RB decreased the percentage of DU145 cells in S phase 
(Fig.  4a  and  Supplementary  Table  2).  The  result  of  laser  scanning  cytometry 
indicated a 71% (P<0.01) decrease in the S phase fraction of cells when DU145 cells 
were treated with RB for 28 days. SB also inhibited the progression of DU145 cells 
from G0/G1 to S phase; at that time cells are committed to replication. These results 
indicated that  RB induced G1 arrest.  Similar  changes were observed in PC-3 and 
LNCaP cells (Fig. 4a and Supplementary Table 2). The results suggest that inhibition 
of deregulated cell cycle progression is one of the molecular events associated with 
selective anticancer efficacy of RB in prostate cancer cells.
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  The regulatory proteins of the checkpoint of G1/S such as CDK inhibitors (p21 and 
p27),  CDK2, CDK4 and CDK6 were affected by RB and RB+SB treatment.  The 
results  showed that  the  expression  of  p21 and p27 was significantly  increased  in 
DU145 and PC-3 cells with RB and RB+SB treatment, but not in LNCaP cells. The 
expression of CDK2 was decreased in LNCaP cells, and the expression of CDK4 was 
decreased in DU145 and PC-3 cells with RB and RB+SB treatment. The expression 
of CDK6 was decreased in DU145 and PC-3 cells with RB treatment, but increased 
by RB+SB (Fig. 5a). These results suggested that RB and RB+SB caused G1 arrest by 
up-regulation of p21 and p27 expression in DU145 and PC-3 cells, and inhibition of 
CDK2, CDK4 or CDK6 in all prostate cancer cells.  
RB ± SB induce apoptosis in prostate cancer cells
After treatment of prostate cancer cells with RB for 28 days, apoptotic cells were 
detected by laser scanning cytometry. DU145, PC-3 and LNCaP cells treated with RB 
for  28  days  exhibited  a  sub-G1 peak  in  laser  scanning  cytometry  (Fig.  4a).  Cell 
morphology  under  laser  scanning  microscopy  showed  condensed  and  fragmented 
nuclei in these prostate cancer cells (Fig. 4b). The results showed that RB induced 
apoptosis in all three prostate cancer cell lines. 
  Several  proteins,  including poly  (ADP-ribose)  polymerase  (PARP),  play  an 
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important  role  in  the  condensation  and  degradation  of  cell  chromatin  through 
apoptotic  death.  The  cleavage  of  PARP  protein  is  considered  as  an  important 
biomarker of apoptosis. RB treatment caused a moderate degradation of pro-PARP 
protein  in  LNCaP cells.  RB+SB treatment  caused  significant  degradation  of  pro-
PARP protein in all prostate cancer cells, and its degradation was stronger than that 
with SB treatment (Fig. 5b). These results suggested that RB and RB+SB induced 
apoptosis of prostate cancer cells by activating PARP cleavage.
  We also analyzed the level of caspase-3, which is known to be the main effector 
caspase in most mammalian cells.  We showed that the expression of procaspase-3 
was  significantly  down-regulated  in  DU145,  PC-3  and  LNCaP  cells  undergoing 
apoptosis during treatment with RB (28 days) + SB (7 days), and the degradation was 
stronger than that with SB (7 days) treatment alone. Expression of procaspase-3 was 
also significantly down-regulated in LNCaP cells and slightly down-regulated in PC-
3 cells during treatment with RB for 28 days (Fig. 5b). These results suggested that 
RB- and RB+SB-induced apoptosis of prostate cancer cells were mediated through 
caspase-3. 
  RB  treatment  caused  significant  induction  of  Bcl-2  and  Bcl-xL  expression. 
Furthermore, expression of Bcl-2 was significantly decreased in LNCaP cells, Bcl-xL 
expression was moderately decreased in PC-3 and LNCaP cells, and Bax expression 
was not significantly changed in PC-3 and LNCaP cells (Fig, 5b). In DU145 cells, 
Western blot analysis did not reveal the presence of Bcl-2 or Bax. Treatment of cells 
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with RB+SB significantly induced the expression of  Bcl-2 in PC-3 cells,  and the 
degradation was stronger than that with SB treatment. These data suggested that RB 
and RB+SB induced apoptosis of PC-3 and LNCaP cells through the Bcl-2- and Bcl-
xL-mediated apoptosis pathway.
  As shown in Fig. 5b, DU145 and LNCaP cells treated with RB+SB exhibited a 
significant increase in the expression of TRADD and FADD, death adaptor proteins, 
and the increase was greater than that with SB treatment alone. DU145 cells treated 
with RB also exhibited a significant increase in the expression of Fas death receptor 
protein. These data suggested that RB induced apoptosis of DU145 cells through a 
Fas-mediated pathway. RB+SB also induced apoptosis in DU145 and LNCaP cells 
through a Fas-mediated pathway. 
Apoptotic effect of RB on tumor growth in vivo
We examined the  inhibitory  effects  of  RB to  the  growth of  prostate  cancer  cells 
transplanted into nude mice. The growth curves for prostate cancer xenografts are 
shown in Figure 6 a-c. There was a significant decrease of 16.7% (*p<0.05) in tumor 
volume on the 70th day in DU-145, 53.1% (*p<0.05) on the 74th day in PC-3, and 
67.1% (*p<0.05) on the 15th day in LNCaP as a result of RB treatment. The result 
showed  that  RB  had  an  inhibitory  effect  in  vivo against  proliferation  of  human 
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prostate cancer cells.
  Apoptosis was demonstrated by the TUNEL reaction in the xenografts mice tissues. 
Apoptosis was clearly shown by scattered TUNEL-positive cells in sections of all 
prostate cancer tissue when the xenografts mice were exposed to RB, but not shown 
without RB exposure (Fig 6d).
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Discussion
The  response  of  hormone-refractory  prostate  cancer  to  chemotherapy  remains 
modest, necessitating the search for new forms of treatment to improve the prognosis. 
This study is believed to be the first to show that exposure to RB was effective at 
inhibiting the growth of human prostate cancer cells (DU145, PC-3 and LNCaP), and 
RB+SB at low concentration induced complete eradication of these cancer cells  in  
vitro. In addition tumor growth of all three prostate cancer cells was also significantly 
suppressed in vivo. Our data also suggest that RB-induced growth inhibition of cancer 
cells was associated with strong G1 phase arrest, by increasing p21 expression, which 
resulted in CDK2, CDK4 or CDK6 down-regulation. The apoptosis induced by RB 
and RB+SB is thought to be mediated by a Bcl-2 and Fas signaling pathway.
  The genes involved in the suppression of cancer growth are more or less inactivated 
in patients with cancer, which results in oncogene-activation in these patients. This 
condition may be induced by the gene mutation, but usually it explains approximately 
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10% of all cancers. The most problem of cancer research is in the object of research, 
since all kinds of scientific analysis including gene mutation in cancer cells is done 
after cancer is established. The total number of genes in humans is 20 000-25 000, 
but the number of active genes decreases with aging.  
  It is well known that histone acetyl transferase opens up the space of histones that 
allows specific  transcription factors  to bind the promoter  to activate the structure 
gene. This will produce proteins available for keeping a man in healthy homeostasis 
under normal condition. If cells are exposed to HDACis, it may be that the genes 
remain active, which may give more opportunity for silent genes to be reactivated. In 
addition, the increase of temperature at a certain degree may give more chances of 
the  transcription  factors  to  bind  the  promoters  by  increasing  rate  of  molecular 
collisions according to Arrhenius plot resulting in reactivation of the silent and/or 
inactive genes.  
  Taking  into  consideration  that  various  kinds  of  gene  activation  in  the  cDNA 
microarray clustering analysis, and the inhibition of cancer growth observed by the 
exposure  of  prostate  cancer  cells  to  RB,  it  appears  that  far-infrared  rays  play an 
important role in the gene activation. 
  The reason why RB has such high emittance of far-infrared rays is due to many 
closed  cells  exist  in  the  RB (20  to  30  cells  /  mm2).  Since  RB has  much  larger 
development area and can receive many infrared rays e.g. from the sun and heat - 
generating objects.  
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  When a  spectral  emittance was measured,  it  was found that  RB has  a  spectral 
emittance close to “1 (100%)” in the area from 4 m to 25 m, which is equal to aμ μ  
spectral emittance of virtual black body similar to a sunspot.  
  The temperature difference after  exposure of the culture medium to RB is only 
0.36°C. The main wavelength of far-infrared rays emitted form RB is 4 - 25  µm. 
Calculating from the velocity of light, the frequency of far-infrared rays at 4 - 25 µm 
is 1.2 ~ 7.5 x 1013, which is not a sufficient energy level to increase the temperature of 
the culture medium by 0.36°C. The energy needed to increase the temperature of 1 g 
water by  1°C is  4.184  J.  Therefore,  it  will  be  1.51  J  in  order  to  increase  the 
temperature by 0.36°C. From Planck’s formula, the frequency of the wave to raise the 
temperature by 0.36°C must be 2.27×1033 /s. To explain this discrepancy between the 
two energy levels, it might be assumed that there exists the structure-based substance 
wave at frequency of 2.27 ×1033  /s, which is probably generated from molecules by 
resonance in culture media and cells when they are exposed to far-infrared rays. The 
increased temperature caused by constant exposure to far-infrared rays increases the 
collision rate among molecules, according to the equation of the Arrhenius plot. The 
increase of collision rate may be small, but estimating the tremendous numbers of the 
combinations of molecules in the cells, the collisions may be significant to activate 
interrelation among the molecules necessary for activation of the silent genes, which 
induced mRNA re-expression and re-activation of apoptotic pathway as were shown 
in the Figure 3a & b. Acetyl transferase alters chromatin structure and dynamically 
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affects transcription regulation. HDACis keep an altered chromatin structure and are 
highly  effective  in  up-regulating  suppressor  gene  expression.  The  increased 
temperature  induced by far-infrared  rays  may lead  to  up-regulation  of  suppressor 
and/or apoptotic genes, especially in the presence of HDACi in cancer cells. In this 
study, treatment of cells with RB+SB significantly induced expression of Bcl-2 and 
Bcl-XL, and considerably increased expression of TRADD and FADD proteins.
  Apoptosis  plays an important  role  in  the renewal  of  the  normal  and neoplastic 
prostatic  epithelium,  and reduced  apoptosis  is  associated  with  the  progression  of 
locally invasive prostate cancers to metastatic disease. Restoring apoptosis has been 
suggested as a possible therapeutic strategy, therefore, a great deal of research has 
been devoted to understanding the abnormalities in the cellular machinery that cause 
resistance  to  apoptosis  in  prostate  cancer  cells.  Increasing evidence  indicates  that 
impaired ability to undergo apoptosis plays an important role in the evolution from 
androgen-dependent  to  androgen-independent  prostate  cancer,  as  well  as  drug 
resistance.  Thus,  much  effort  is  being  directed  toward  finding  ways  to  increase 
apoptosis in prostate cancer. In this study, we showed that RB and RB+SB induced 
apoptosis. In addition, it is very important that RB did not harm the growth of normal 
prostate epithelium, and rather  increased the number of normal prostate epithelial 
cells in the presence of SB, otherwise growth was suppressed by SB.
  This is believed to be the first report  of the biological action of RB in prostate 
cancer cell lines. We demonstrated that prostate cancer cell lines were sensitive to RB 
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and RB+SB  in vitro and  in vivo. Two distinct signaling pathways were involved in 
RB-mediated cell growth arrest and induction of apoptosis. These results present a 
new  therapeutic  modality,  especially  in  hormone-refractory  prostate  cancer,  and 
theoretically RB might be helpful to control various kinds of cancer.
Methods Summary
The activated form (RB) made of natural or synthetic rubber/resin was obtained from 
Yamamoto Corporation (Osaka, Japan) (Fig. 1d). RB consisted of rubber, lime stone 
and  titanium metal  powder  in  a  honeycomb structure  comprised  of  micron-sized 
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cells, and had the ability to radiate far-infrared rays (4-25  µm) and maintain body 
temperature.  The  spectral  emissivity  2500  cm-1-  400  cm-1 (4  µm  -  25  µm)  was 
measured  at  the  measuring  temperature  90°C,  Discrimination  8  cm-1 and  the 
integrated 200 times testing by SIMADZ Fourier transform infrared spectrophtometer 
FTIR - 4300 (Figure 1d). Spectral Transmission of RB in the infrared region was 
measured by SHIMADZU infrared spectrophotometer IR-470.
  The DU145,  PC-3,  LNCaP and PrECs  were  maintained  in  Minimum Essential 
Medium, F-12K medium, RPMI medium and
 
prostate epithelial cell basal medium in 
an atmosphere of 5% CO2 at 37°C. 
  For determining cell proliferation, viable cell numbers were counted using the Cell 
Proliferation  Kit  II  (Roche Diagnostics,  Mannheim,  Germany)  based  on  the  XTT 
assay.
  Hierarchical clustering was applied to both axes using the unweighted pair-group 
method, with the arithmetic average as implemented in the program GeneSpring5.1 
(Agilent Technologies, Santa Clara, CA, USA). Messenger RNA for TNF associated 
genes related to apoptosis  which showed strong signal intensity were confirmed by 
RT-PCR independently. 
  Cell cycle and apoptosis analysis were examined under a laser scanning microscope 
(Olympus  BX51;  Olympus  Optics,  Tokyo,  Japan).  Effect  of  RB  and  RB+SB  on 
expression of apoptotic proteins was performed with Western blotting.
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  To explore the relevance of our findings in vivo, we examined the inhibitory effects 
of  RB  by  tumor  xenograft  studies,  apoptosis  was  demonstrated  by  the  TUNEL 
reaction in the xenografts mice tissues.
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 Table 1 | Effect of RB, SB and RB + SB on the growth of DU145, PC-3, LNCaP and PrEC cells
                       
Alive cell number (%) on the 29
  
th 
  
day                             
 
              
DU145    
 
             PC-3                    LNCaP                  PrEC          
  SB      RB (-)     RB (+)      RB (-)       RB (+)       RB (-)     RB (+)       RB (-)       RB (+)
            
0 mM   549.6 ± 0.4   224.3 ± 5.3*  859.9 ± 45.9  370.8 ± 69.9*  401.4 ± 23.4  274.8 ± 18.2*  100.0 ± 9.7   169.2 ± 18.3+
1 mM   546.4 ± 0.1    56.8 ± 9.9*  847.0 ± 29.9  204.9 ± 44.6*  146.9 ± 10.1   22.0 ± 10.6*   73.2 ± 7.9+   111.6 ± 17.9#
2 mM   525.4 ± 10.5    4.8 ± 0.4*  622.1 ± 96.9   38.0 ± 13.2*  49.2 ± 4.7      0.0 ± 0.0*    75.7 ± 7.8+  111.4 ± 12.7#
3 mM   
 
100.0 
 
±
  
 15.0    0.0 ±
  
 0.0
 *   301.4  ±   47.8    0.0 ±   0.0 *     6.8  ±   2.2      0.0 ±   0.0 *     76.8  ±   8.1 +   224.9  ±   16.9 *   
Data shown are the mean ± SD (%). +, p< 0.01; #, p < 0.001; *, p < 0.0001.
Table 2 | Effect of RB treatment on cell cycle and apoptosis 
Cell line     RB         G0         G1         S         G2         M       sub-G1     
DU145  
    
−
         0.3 ± 0.2    56.1 ± 1.8    15.4 ± 1.5    14.9 ± 0.9     0.9 ± 0.5     0.5 ± 0.1  
           
+         1.4 ± 0.5    67.5 ± 3.1+    1.5 ± 1.3#     9.8 ± 1.9     0.6 ± 0.2     6.4 ± 0.4*  
PC-3         −        12.4 ± 1.3    54.9 ± 1.2     6.9 ± 0.2      6.9 ± 1.1     1.4 ± 0.1     0.7 ± 0.4  
           
+         2.3 ± 0.2    82.8 ± 1.9*    1.4 ± 0.2*     2.2 ± 0.4     0.2 ± 0.1     6.2 ± 0.2*  
LNCaP
     
−
         0.4 ± 0.2     59.3 ± 1.4   16.1 ± 0.7      12.5 ± 1.5     0.9 ± 0.3     0.1 ± 0.1  
              +        0.8 ±
  
 0.8     63.3 ±
  
 2.3    12.7 ±
  
 1.3
 
φ
 
     11.3 ±
  
 1.5     0.9 ±
  
 0.7     3.1 ±
  
 0.2
 *    
Data shown are the mean
 
±
 SD (%). φ, p < 0.05; +, p < 0.01; #, p < 0.001; *, p < 0.0001       
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Figure legends
Figure  1  |  The spectral  emissivity  and  transmissivity  of  RB,  and 
experimental design. (a) The spectral emissivity (4 µm - 25 µm) was measured at 
the measuring temperature 90°C. The respective spectrum of the spectral emissivity 
of a dummy blackbody as well as of RB are shown. Conversion formula is shown as 
Xµm =10000/Y cm-1 (for example: 10000/400 cm-1=25 µm). Spectral Transmission of 
RB in the infrared region was measured, and transmissivity was Zero (0) at 4000 - 
400 cm-1 (Data not shown). (b) Prostate cancer cells were cultured in 10-cm dishes 
which were exposed to RB whose silver color side toward cells. (c) Prostate cancer 
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cells were cultured with or without RB for 21 days, and SB was then added to the 
culture medium at 2 mM for 7 days. (d) Activated form of RB with a honeycomb 
structure  comprised  of  micron-sized  cells  (20-30/mm3)  inside  has  the  ability  to 
radiate far-infrared rays (4-25 µm).
Figure  2 | Effects  of  RB,  SB and  RB+SB on  the  growth  of  prostate 
cancer cell lines and human prostate epithelial cells. (a) DU145, (b) PC-3, 
(c) LNCaP, and (d) human prostate epithelial cells. DU145, PC-3, LNCaP and human 
prostate epithelial cells were treated with RB (21 days) with or without 0.2% PBS (-) 
or 1, 2 and 3 mM SB for 8 days; cells were counted 29 days by XTT assay. Data from 
three  independent  experiments  are  shown  as  means  ± SD.  +P<0.01,  #P<0.001, 
*P<0.0001.
Figure  3 | Hierarchical  clustering  analysis  in  treatment  of  prostate 
cancer  cell  lines  by  RB,  SB  and  RB+SB. (a) Gene  expression  profile. 
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Representative  results  of  hierarchical  clustering  human  cDNA  (1.2k)  microarray 
analysis after  21 and 28 days exposure to RB are shown. RB showed remarkable 
activation of mRNA in DU145, PC-3, and LNCaP cells. In combination of 2 mM SB 
for  7  days  which  the  culture  media  were  exposed  by  RB  for  21  days,  mRNA 
expressions were intensified in the presence of 2 mM SB which the culture media 
were exposed by RB for 21 days. (b) mRNA of TNF associated genes was activated 
in the presence of RB for 21 days. Each row represents the mean of signal log ratios 
using a color-code scale. Red represents expression that was two-fold greater than the 
reference value;  pink represents expression that was 1.4-fold greater than reference; 
and green represents expression that was 0.5-fold less than reference.
Figure 4 | Effect of RB on the cell cycle and apoptosis in prostate cancer 
cell lines. DU145, PC-3, and LNCaP cells were treated with RB for 28 days and 
stained for nuclear DNA with propidium iodide (PI). (a) The intensity of PI staining 
was  analyzed  with  the  use  of  a  microscope-based  multiparameter  laser  scanning 
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cytometer. 1, G0; 2, G1; 3, S; 4, G2; 5, M; 6, apoptosis (b) Apoptosis (arrow) induced 
by RB was observed by laser scanning microscopy. Cancer cells were fragmented.
Figure  5 |  Effect  of  RB and  RB+SB on  the  expression  of  cell  cycle 
regulators
 (a)  and  apoptosis-associated  gene  expression (b).  The 
expression of p21, p27, CDK2, CDK4, CDK6, Fas, FADD, TRADD, Bcl-2, Bcl-xL, 
Bax, procaspse-3 and pro-PARP were determined by Western blotting. Equal loading 
(30 µg) was confirmed by stripping immunoblots and reprobing them for β-actin. The 
experiment was independently repeated three times with similar results. 
.
Figure 6 | Inhibition of prostate cancer tumor growth and apoptosis by 
RB  in  vivo.
 
(a-c)  RB  effects  on  tumor  volumes  in  vivo:  Tumor  volumes  are 
chronogically  shown  in  RB-treated  and  -untreated  xenografts  as  described  in 
methods. Each column shows the mean  ± S.E.M. of tumor volumes measured in 4 
xenografts  mice.  There  was  a  significant  decrease  of  16.7% (*p<0.05)  in  tumor 
volume on the 70th day in DU-145, 53.1% (*p<0.05) on the 74th day in PC-3, and 
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67.1%  (*p<0.05)  on  the  15th day  in  LNCaP  as  a  result  of  RB  treatment. (d) 
Representative micrograph of DNA end-labelling (TUNEL) of tissue sections from 
mice by RB (+) and RB (-) groups. TUNEL labelling of DU145, PC-3 and LNCaP 
sections  from RB-treated  mouse  reveals  positive  staining  and propidium iodide - 
detected DNA strand break (arrow). Magnification  ×400.  Neither TUNEL-positive 
nor DNA strand breaks cells were observed in cancer tissue sections when they were 
not exposed to RB. Magnification ×400. 
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